|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
29 May 2023 |
|
Main ID: |
NCT03973502 |
|
Date of registration:
|
30/05/2019 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD
|
|
Scientific title:
|
Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) in Research of the Association Between HCV Infection and Parkinson's Disease. |
|
Date of first enrolment:
|
June 12, 2017 |
|
Target sample size:
|
230 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03973502 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Taiwan
| | | | | | | |
|
Contacts
|
|
Name:
|
Yen Ruoh Fang, MD, PhD |
|
Address:
|
|
|
Telephone:
|
886-2-23123456 |
|
Email:
|
rfyen@ntu.edu.tw |
|
Affiliation:
|
|
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Test Group
1. Age:above 20 years old with HBV or HCV subjects.
2. Patient agrees to participate in the study and receive UPDRS, MMSE, BDI II, MRI
and PET imaging.
- Control Group
1. Age:above 20 years old without carriers of Hepatitis B and C (ex. fatty liver),
and no known neurological (ex. stroke, Parkinson's disease and degenerative
neuropathy, etc.) and mental illness.
2. Patient agrees to participate in the study and receive UPDRS, MMSE, BDI II, MRI
and PET imaging.
Exclusion Criteria:
1. Patients could not receive PET and MRI studies, including panic mood to MRI study,
allergy to contrast medium, hemodynamic instability.
2. Patients with pregnancy or recently having a plan for pregnancy.
3. Patient or family who does not agree to participate in the study
Age minimum:
20 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Hepatitis B
|
|
Hepatitis C
|
|
Parkinson Disease
|
|
Intervention(s)
|
|
Drug: 18F-DOPA PET
|
|
Primary Outcome(s)
|
|
PET imaging
[Time Frame: in 3 days]
|
|
Secondary ID(s)
|
|
201506041MINA
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|